DeMay Bio

DeMay Bio is developing a biologic drug for Rheumatoid Arthritis that leverages a natural human protein to target a novel, but validated, disease mechanism directly in the joints. The new drug is an adjunct therapy, to be used alongside a patient’s immunosuppressant regimen,  to achieve better disease control, and to reduce disabling joint pain, tissue…

Read More

Bow Therapeutics

Bow Therapeutics is developing isolation of human monoclonal antibodies against Chikungunya Virus Glycoprotein using Single B-cell sorting Technology.   Bow Therapeutics Team: George Georgiev Jose Quiroz    

Read More

Halo Mountain

Halo Mountain’s drug has the potential to stop Alzheimer’s disease by fighting inflammation and oxidative stress.   Halo Mountain Team: Eleanor Haglund  

Read More

CapCell Biologics

CapCell Biologics is treating rare diseases with implants composed of engineered cells in a protective mesh capsule.   CapCell Biologics Team: Ben Young Jon Zaikowski    

Read More

OstoCare

OstoCare is an integrated solution for ostomy patients designed to reduce odors and leakage while simplifying the difficult ostomy bag changing process. Team: Wilson Ho

Read More

Landos Biopharma

Landos Biopharma (formerly Biotherapeutics) is a science-based company that is advancing novel, oral, small molecules to treat inflammation and diabetes towards IND and clinical trials. Landos Biopharma Team: Adria Carbo Josep Bassaganya-Riera

Read More

Zakan Theraputics

Zakan Therapeutics — A biological therapeutic that can directly attack metastatic cancer cells by delivering a payload of anti-cancer compounds while bypassing healthy cells. Zakan Theraputics Team: Arthee Jahangir Benjamin Caballero

Read More

Novyx Technologies

A cost-effective hydrogel dressing for chronic wounds, which enhances wound healing, reduces inflammation, risk of infection and pain, as well as provides comfort during use. Novyx Technologies Team: Waleed Abdel-Naby, PhD

Read More

Jotteq

Jot is a new kind of eye drop dispenser that is safe and easy to use. My objective is to bring it to market Jotteq Team: Nigel Kelly

Read More